BIOJECT RECEIVES MEDICAL DEVICE REGISTRATION IN NIGERIA
Post# of 9
Posted On: 12/29/2014 5:39:22 PM
BIOJECT RECEIVES MEDICAL DEVICE REGISTRATION IN NIGERIA
Tigard, OR – December 22, 2014 – Bioject Medical Technologies Inc. (OTC Pink: BJCT), a leading developer and manufacturer of needle-free injection therapy systems, announced that iHealthNet, LLC and its sub-distributor in the Federal Republic of Nigeria have received registration approval covering all of Bioject’s
“As we have achieved in the Philippines, Australia, Singapore and several other territories this year, the registration in Nigeria shows our commitment to making Bioject technology available throughout the world”, commented Mark Logomasini, Bioject’s President and CEO, “We are in the registration queue in another half dozen countries with more coming. And to support these efforts, we hired a full-time regulatory affairs manager this month with considerable experience in this area.”
Bioject Medical Technologies Inc., based in Tigard, Oregon, USA, is an innovative developer and manufacturer of needle-free injection therapy systems (NFITS). NFITS works by forcing medication at high speed through a tiny orifice held against the skin. This creates a fine stream of high-pressure fluid penetrating the skin and depositing medication in the tissue beneath. Bioject is focused on developing mutually beneficial agreements with leading pharmaceutical, biotechnology, and veterinary companies, as well as research, global health and government organizations.
Bioject (OTC Pink: BJCT) trades on the OTC Pink tier of the OTC market. Investors can find Real-Time quotes and market information for the Company on www.otcmarkets.com.
Tigard, OR – December 22, 2014 – Bioject Medical Technologies Inc. (OTC Pink: BJCT), a leading developer and manufacturer of needle-free injection therapy systems, announced that iHealthNet, LLC and its sub-distributor in the Federal Republic of Nigeria have received registration approval covering all of Bioject’s
“As we have achieved in the Philippines, Australia, Singapore and several other territories this year, the registration in Nigeria shows our commitment to making Bioject technology available throughout the world”, commented Mark Logomasini, Bioject’s President and CEO, “We are in the registration queue in another half dozen countries with more coming. And to support these efforts, we hired a full-time regulatory affairs manager this month with considerable experience in this area.”
Bioject Medical Technologies Inc., based in Tigard, Oregon, USA, is an innovative developer and manufacturer of needle-free injection therapy systems (NFITS). NFITS works by forcing medication at high speed through a tiny orifice held against the skin. This creates a fine stream of high-pressure fluid penetrating the skin and depositing medication in the tissue beneath. Bioject is focused on developing mutually beneficial agreements with leading pharmaceutical, biotechnology, and veterinary companies, as well as research, global health and government organizations.
Bioject (OTC Pink: BJCT) trades on the OTC Pink tier of the OTC market. Investors can find Real-Time quotes and market information for the Company on www.otcmarkets.com.
(0)
(0)Bioject Medical Technologies Inc. (BJCT) Stock Research Links
Scroll down for more posts ▼